 | • レポートコード：QYR2104Z2658 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、有毛細胞白血病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法薬、免疫療法薬）、用途別市場規模（病院、薬局、がん研究機構）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・有毛細胞白血病治療の市場動向 ・企業の競争状況、市場シェア ・有毛細胞白血病治療の種類別市場規模（化学療法薬、免疫療法薬） ・有毛細胞白血病治療の用途別市場規模（病院、薬局、がん研究機構） ・有毛細胞白血病治療の北米市場規模2016-2027（アメリカ、カナダ） ・有毛細胞白血病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・有毛細胞白血病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・有毛細胞白血病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・有毛細胞白血病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche、Janssen Global Services、Dr. Reddy's Laboratories、Emcure Pharmaceuticals、Amgen、Hospira、Astex Therapeutics、AbbVie、Astellas Pharma、AstraZeneca、Biogenomics） ・結論 |
Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells.
It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can be the rural or country side population which is exposed to fertilizers and aging population, due to its rarity it has been difficult to diagnose the cause and thus cannot be associated with any activity or behavior.
Market Analysis and Insights: Global Hairy cell Leukemia Treatment Market
The global Hairy cell Leukemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hairy cell Leukemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hairy cell Leukemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hairy cell Leukemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hairy cell Leukemia Treatment market.
Global Hairy cell Leukemia Treatment Scope and Market Size
Hairy cell Leukemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hairy cell Leukemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy Drugs
Immunotherapy Drugs
Segment by Application
Hospitals
Pharmacies
Cancer Research Organization
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann-La Roche
Janssen Global Services
Dr. Reddy’s Laboratories
Emcure Pharmaceuticals
Amgen
Hospira
Astex Therapeutics
AbbVie
Astellas Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hairy cell Leukemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy Drugs
1.2.3 Immunotherapy Drugs
1.3 Market by Application
1.3.1 Global Hairy cell Leukemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Cancer Research Organization
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hairy cell Leukemia Treatment Market Perspective (2016-2027)
2.2 Hairy cell Leukemia Treatment Growth Trends by Regions
2.2.1 Hairy cell Leukemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hairy cell Leukemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hairy cell Leukemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hairy cell Leukemia Treatment Industry Dynamic
2.3.1 Hairy cell Leukemia Treatment Market Trends
2.3.2 Hairy cell Leukemia Treatment Market Drivers
2.3.3 Hairy cell Leukemia Treatment Market Challenges
2.3.4 Hairy cell Leukemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hairy cell Leukemia Treatment Players by Revenue
3.1.1 Global Top Hairy cell Leukemia Treatment Players by Revenue (2016-2021)
3.1.2 Global Hairy cell Leukemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hairy cell Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hairy cell Leukemia Treatment Revenue
3.4 Global Hairy cell Leukemia Treatment Market Concentration Ratio
3.4.1 Global Hairy cell Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hairy cell Leukemia Treatment Revenue in 2020
3.5 Hairy cell Leukemia Treatment Key Players Head office and Area Served
3.6 Key Players Hairy cell Leukemia Treatment Product Solution and Service
3.7 Date of Enter into Hairy cell Leukemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hairy cell Leukemia Treatment Breakdown Data by Type
4.1 Global Hairy cell Leukemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hairy cell Leukemia Treatment Forecasted Market Size by Type (2022-2027)
5 Hairy cell Leukemia Treatment Breakdown Data by Application
5.1 Global Hairy cell Leukemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hairy cell Leukemia Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hairy cell Leukemia Treatment Market Size (2016-2027)
6.2 North America Hairy cell Leukemia Treatment Market Size by Type
6.2.1 North America Hairy cell Leukemia Treatment Market Size by Type (2016-2021)
6.2.2 North America Hairy cell Leukemia Treatment Market Size by Type (2022-2027)
6.2.3 North America Hairy cell Leukemia Treatment Market Size by Type (2016-2027)
6.3 North America Hairy cell Leukemia Treatment Market Size by Application
6.3.1 North America Hairy cell Leukemia Treatment Market Size by Application (2016-2021)
6.3.2 North America Hairy cell Leukemia Treatment Market Size by Application (2022-2027)
6.3.3 North America Hairy cell Leukemia Treatment Market Size by Application (2016-2027)
6.4 North America Hairy cell Leukemia Treatment Market Size by Country
6.4.1 North America Hairy cell Leukemia Treatment Market Size by Country (2016-2021)
6.4.2 North America Hairy cell Leukemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Hairy cell Leukemia Treatment Market Size (2016-2027)
7.2 Europe Hairy cell Leukemia Treatment Market Size by Type
7.2.1 Europe Hairy cell Leukemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hairy cell Leukemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hairy cell Leukemia Treatment Market Size by Type (2016-2027)
7.3 Europe Hairy cell Leukemia Treatment Market Size by Application
7.3.1 Europe Hairy cell Leukemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hairy cell Leukemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hairy cell Leukemia Treatment Market Size by Application (2016-2027)
7.4 Europe Hairy cell Leukemia Treatment Market Size by Country
7.4.1 Europe Hairy cell Leukemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hairy cell Leukemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hairy cell Leukemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Type
8.2.1 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Application
8.3.1 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Region
8.4.1 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hairy cell Leukemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hairy cell Leukemia Treatment Market Size (2016-2027)
9.2 Latin America Hairy cell Leukemia Treatment Market Size by Type
9.2.1 Latin America Hairy cell Leukemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hairy cell Leukemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hairy cell Leukemia Treatment Market Size by Type (2016-2027)
9.3 Latin America Hairy cell Leukemia Treatment Market Size by Application
9.3.1 Latin America Hairy cell Leukemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hairy cell Leukemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hairy cell Leukemia Treatment Market Size by Application (2016-2027)
9.4 Latin America Hairy cell Leukemia Treatment Market Size by Country
9.4.1 Latin America Hairy cell Leukemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hairy cell Leukemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hairy cell Leukemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Type
10.2.1 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Application
10.3.1 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Country
10.4.1 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hairy cell Leukemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Hairy cell Leukemia Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Janssen Global Services
11.2.1 Janssen Global Services Company Details
11.2.2 Janssen Global Services Business Overview
11.2.3 Janssen Global Services Hairy cell Leukemia Treatment Introduction
11.2.4 Janssen Global Services Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.2.5 Janssen Global Services Recent Development
11.3 Dr. Reddy’s Laboratories
11.3.1 Dr. Reddy’s Laboratories Company Details
11.3.2 Dr. Reddy’s Laboratories Business Overview
11.3.3 Dr. Reddy’s Laboratories Hairy cell Leukemia Treatment Introduction
11.3.4 Dr. Reddy’s Laboratories Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.3.5 Dr. Reddy’s Laboratories Recent Development
11.4 Emcure Pharmaceuticals
11.4.1 Emcure Pharmaceuticals Company Details
11.4.2 Emcure Pharmaceuticals Business Overview
11.4.3 Emcure Pharmaceuticals Hairy cell Leukemia Treatment Introduction
11.4.4 Emcure Pharmaceuticals Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.4.5 Emcure Pharmaceuticals Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Hairy cell Leukemia Treatment Introduction
11.5.4 Amgen Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Hospira Business Overview
11.6.3 Hospira Hairy cell Leukemia Treatment Introduction
11.6.4 Hospira Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.6.5 Hospira Recent Development
11.7 Astex Therapeutics
11.7.1 Astex Therapeutics Company Details
11.7.2 Astex Therapeutics Business Overview
11.7.3 Astex Therapeutics Hairy cell Leukemia Treatment Introduction
11.7.4 Astex Therapeutics Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.7.5 Astex Therapeutics Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Hairy cell Leukemia Treatment Introduction
11.8.4 AbbVie Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Hairy cell Leukemia Treatment Introduction
11.9.4 Astellas Pharma Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.9.5 Astellas Pharma Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Hairy cell Leukemia Treatment Introduction
11.10.4 AstraZeneca Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.10.5 AstraZeneca Recent Development
11.11 Biogenomics
11.11.1 Biogenomics Company Details
11.11.2 Biogenomics Business Overview
11.11.3 Biogenomics Hairy cell Leukemia Treatment Introduction
11.11.4 Biogenomics Revenue in Hairy cell Leukemia Treatment Business (2016-2021)
11.11.5 Biogenomics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hairy cell Leukemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Immunotherapy Drugs
Table 4. Global Hairy cell Leukemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hairy cell Leukemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hairy cell Leukemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hairy cell Leukemia Treatment Market Share by Regions (2016-2021)
Table 8. Global Hairy cell Leukemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hairy cell Leukemia Treatment Market Share by Regions (2022-2027)
Table 10. Hairy cell Leukemia Treatment Market Trends
Table 11. Hairy cell Leukemia Treatment Market Drivers
Table 12. Hairy cell Leukemia Treatment Market Challenges
Table 13. Hairy cell Leukemia Treatment Market Restraints
Table 14. Global Hairy cell Leukemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hairy cell Leukemia Treatment Market Share by Players (2016-2021)
Table 16. Global Top Hairy cell Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hairy cell Leukemia Treatment as of 2020)
Table 17. Ranking of Global Top Hairy cell Leukemia Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hairy cell Leukemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hairy cell Leukemia Treatment Product Solution and Service
Table 21. Date of Enter into Hairy cell Leukemia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hairy cell Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hairy cell Leukemia Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Hairy cell Leukemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hairy cell Leukemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hairy cell Leukemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hairy cell Leukemia Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Hairy cell Leukemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hairy cell Leukemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hairy cell Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hairy cell Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hairy cell Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hairy cell Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hairy cell Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hairy cell Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hairy cell Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hairy cell Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hairy cell Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hairy cell Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hairy cell Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hairy cell Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hairy cell Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hairy cell Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hairy cell Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hairy cell Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hairy cell Leukemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hairy cell Leukemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hairy cell Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hairy cell Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hairy cell Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hairy cell Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hairy cell Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hairy cell Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hairy cell Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hairy cell Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hairy cell Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hairy cell Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hairy cell Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hairy cell Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. F. Hoffmann-La Roche Company Details
Table 62. F. Hoffmann-La Roche Business Overview
Table 63. F. Hoffmann-La Roche Hairy cell Leukemia Treatment Product
Table 64. F. Hoffmann-La Roche Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 65. F. Hoffmann-La Roche Recent Development
Table 66. Janssen Global Services Company Details
Table 67. Janssen Global Services Business Overview
Table 68. Janssen Global Services Hairy cell Leukemia Treatment Product
Table 69. Janssen Global Services Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 70. Janssen Global Services Recent Development
Table 71. Dr. Reddy's Laboratories Company Details
Table 72. Dr. Reddy's Laboratories Business Overview
Table 73. Dr. Reddy's Laboratories Hairy cell Leukemia Treatment Product
Table 74. Dr. Reddy's Laboratories Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 75. Dr. Reddy's Laboratories Recent Development
Table 76. Emcure Pharmaceuticals Company Details
Table 77. Emcure Pharmaceuticals Business Overview
Table 78. Emcure Pharmaceuticals Hairy cell Leukemia Treatment Product
Table 79. Emcure Pharmaceuticals Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 80. Emcure Pharmaceuticals Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Hairy cell Leukemia Treatment Product
Table 84. Amgen Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 85. Amgen Recent Development
Table 86. Hospira Company Details
Table 87. Hospira Business Overview
Table 88. Hospira Hairy cell Leukemia Treatment Product
Table 89. Hospira Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 90. Hospira Recent Development
Table 91. Astex Therapeutics Company Details
Table 92. Astex Therapeutics Business Overview
Table 93. Astex Therapeutics Hairy cell Leukemia Treatment Product
Table 94. Astex Therapeutics Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 95. Astex Therapeutics Recent Development
Table 96. AbbVie Company Details
Table 97. AbbVie Business Overview
Table 98. AbbVie Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 99. AbbVie Recent Development
Table 100. Astellas Pharma Company Details
Table 101. Astellas Pharma Business Overview
Table 102. Astellas Pharma Hairy cell Leukemia Treatment Product
Table 103. Astellas Pharma Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 104. Astellas Pharma Recent Development
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Hairy cell Leukemia Treatment Product
Table 108. AstraZeneca Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 109. AstraZeneca Recent Development
Table 110. Biogenomics Company Details
Table 111. Biogenomics Business Overview
Table 112. Biogenomics Hairy cell Leukemia Treatment Product
Table 113. Biogenomics Revenue in Hairy cell Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 114. Biogenomics Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hairy cell Leukemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Drugs Features
Figure 3. Immunotherapy Drugs Features
Figure 4. Global Hairy cell Leukemia Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Pharmacies Case Studies
Figure 7. Cancer Research Organization Case Studies
Figure 8. Hairy cell Leukemia Treatment Report Years Considered
Figure 9. Global Hairy cell Leukemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hairy cell Leukemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hairy cell Leukemia Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Hairy cell Leukemia Treatment Market Share by Regions (2022-2027)
Figure 13. Global Hairy cell Leukemia Treatment Market Share by Players in 2020
Figure 14. Global Top Hairy cell Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hairy cell Leukemia Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hairy cell Leukemia Treatment Revenue in 2020
Figure 16. Global Hairy cell Leukemia Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Hairy cell Leukemia Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hairy cell Leukemia Treatment Market Share by Type (2016-2027)
Figure 20. North America Hairy cell Leukemia Treatment Market Share by Application (2016-2027)
Figure 21. North America Hairy cell Leukemia Treatment Market Share by Country (2016-2027)
Figure 22. United States Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hairy cell Leukemia Treatment Market Share by Type (2016-2027)
Figure 26. Europe Hairy cell Leukemia Treatment Market Share by Application (2016-2027)
Figure 27. Europe Hairy cell Leukemia Treatment Market Share by Country (2016-2027)
Figure 28. Germany Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hairy cell Leukemia Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hairy cell Leukemia Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hairy cell Leukemia Treatment Market Share by Region (2016-2027)
Figure 38. China Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hairy cell Leukemia Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Hairy cell Leukemia Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Hairy cell Leukemia Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hairy cell Leukemia Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hairy cell Leukemia Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hairy cell Leukemia Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hairy cell Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 58. Janssen Global Services Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 59. Dr. Reddy's Laboratories Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 60. Emcure Pharmaceuticals Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 62. Hospira Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 63. Astex Therapeutics Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 64. AbbVie Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 65. Astellas Pharma Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 67. Biogenomics Revenue Growth Rate in Hairy cell Leukemia Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の有毛細胞白血病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hairy Cell Leukemia Therapeutics Market The global Hairy Cell Leukemia Therapeutics market size is projected to reach US$ 119.1 million by 2026, from US$ 86 million in 2019, at a CAGR of 4.8% during 2021-2026. With industry-standard accuracy in analysis and high …- 世界のT細胞急性リンパ芽球性白血病治療市場 2021：企業別、地域別、種類・用途別 The T-cell Acute Lymphoblastic Leukemia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界の白血病治療薬市場規模・現状・予測（2021年-2027年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…
- 世界の急性リンパ性/リンパ芽球性白血病薬市場規模・現状・予測（2021年-2027年） Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. Market Analysis and Insights: Global Acute Lymphocytic/Lymphoblastic Leukemia Drugs Market The global Acute Lymphocytic/Lymphoblastic Leukemia…
- 世界の慢性骨髄性白血病治療市場規模・現状・予測（2021年-2027年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…